Recruiting studies: Intraprostatic Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer
NA · 1 location(s) · Center Eugene Marquis · NCT07189598 Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prost
NA · 1 location(s) · German Oncology Center, Cyprus · NCT07568613 Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiot
NA · 1 location(s) · NYU Langone Health · NCT07142967 Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT
NA · 1 location(s) · Fundacao Champalimaud · NCT04035642 CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr
NA · 1 location(s) · European Institute of Oncology · NCT06331013 Dose Escalation For INtraprostatic LEsions
Phase 2 · 1 location(s) · Ottawa Hospital Research Institute · NCT05851547 Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer
NA · 2 location(s) · Region Skane · NCT06220435

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.